Phase 2 study of carfilzomib (CFZ) with or without filanesib (FIL) in patients with advanced multiple myeloma (MM) Meeting Abstract
| Authors: | Zonder, J. A.; Usmani, S.; Scott, E. C.; Hofmeister, C. C.; Lendvai, N.; Berdeja, J. C.; Anderson, L. D.; Hari, P.; Singhal, S.; Orloff, G.; Craig, M.; Valent, J.; Lee, W.; Hart, L.; Hrom, J.; Tarantolo, S.; Faber, E.; Schiller, G. J.; Schreiber, J.; Oliver, C.; Rush, S. A.; Tunquist, B.; Ptaszynski, M.; Raje, N. S. |
| Abstract Title: | Phase 2 study of carfilzomib (CFZ) with or without filanesib (FIL) in patients with advanced multiple myeloma (MM) |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019002165 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.728.728 |
| Notes: | Meeting Abstract: 728 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
